Genocea Biosciences, Inc.

Ownership Transactions Reported by 23 Insiders

Industry
Biological Products, (No Diagnostic Substances)
Location
100 Acorn Park Drive, Cambridge, Massachusetts

There are no Buy or Sell transactions made by insiders since 9/9/2023

Genocea Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
William Clark President and CEO, Director $380K Jun 2, 2022
Jessica Flechtner Chief Scientific Officer $111K Jun 2, 2022
Diantha Duvall Chief Financial Officer $94.2K Jun 2, 2022
Girish Aakalu Chief Business Officer $93.1K Apr 4, 2022
Thomas Davis Chief Medical Officer $85.4K Apr 4, 2022
Raymond D. Stapleton Jr Chief Technology Officer $54.7K May 25, 2022
Jacquelyn Sumer Chief Legal & Compliance Off $53.8K Jun 1, 2022
George Siber Director $315 May 27, 2022
Michael J. Higgins Director Jul 1, 2021
Katrine Bosley Director Jul 1, 2021
John Lunger Director Mar 3, 2022
Carmen Chang 10%+ Owner May 24, 2022
New Enterprise Associates 16, L.P. 10%+ Owner May 24, 2022
Forest Baskett 10%+ Owner May 24, 2022
Scott D. Sandell 10%+ Owner May 24, 2022
Kenneth Bate Director Jul 1, 2021
Ali Behbahani Director, 10%+ Owner May 24, 2022
Anthony A. Florence Jr. 10%+ Owner May 24, 2022
Paul Edward Walker 10%+ Owner May 24, 2022
Mohamad Makhzoumi 10%+ Owner May 24, 2022
Gisela Schwab Director Jul 1, 2021
Peter W. Sonsini 10%+ Owner May 24, 2022
Jennifer Lyn Herron Director Sep 9, 2021

Recent Insider Transactions by Companies or Individuals for Genocea Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.